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Definition  
Atherosclerosis ( arteriosclerotic vascular disease – ASVD, 
arteriosclerotic cardiovascular disease – ASCVD) is a 
disease affecting arterial blood vessels due to a chronic 
inflammatory response on cholesterol depositions  within 
their walls by the formation of multiple atheromatous 
plaques  and  vascular lumens narrowing with 
manifestation in  numerous clinical syndromes from 
sudden cardiovascular death, acute heart and brain 
attacks, cognitive decline and dementia, heart and renal 
failure up to peripheral artery disease 
 en.wikipedia.org/wiki/Atherosclerosis 
Epidemiology    
(Focus on Key Points) 
• ASVD is a rising epidemic with severe health and economic 
consequences for all world regions, affecting men and women 
• ASVD is the leading cause of death worldwide resulting in 17 
million deaths per year 
• ASVD begins early in life, and is a chronically progressive 
disorder that is initiated and progressively advanced by 
specific lifestyle conditions and genetic factors 
•  ASVD disease worsens exponentially with increasing age and 
the burden of atherosclerotic disease is expected to double by 
2030 as the population ages  
casinapioiv.va/content/dam/accademia/pdf/atherosclerosis.pdf 
Epidemiology   
(Prevalence of ASVD by Race) 
indiana.edu/~k562/images/athero/atherorace.jpg 
Risk Factors 
(Modifiable) 
en.wikipedia.org/wiki/Atherosclerosis 
• Diabetes or impaired glucose tolerance (IGT)   
• Dyslipoproteinemia (unhealthy patterns of serum proteins 
carrying fats & cholesterol):   
– High serum concentration of low-density lipoprotein (LDL), 
and / or very low density lipoprotein (VLDL) particles  
– Low serum concentration of functioning high density 
lipoprotein (HDL) 
–  An LDL:HDL ratio greater than 3:1 
• Tobacco smoking  
• Elevated serum C-reactive protein concentrations 
• Vitamin B6 deficiency 
• Dietary iodine deficiency and hypothyroidism  
Risk Factors 
(Nonmodifiable) 
en.wikipedia.org/wiki/Atherosclerosis 
• Advanced age 
• Male sex 
• Having close relatives who have had some complication of 
atherosclerosis (e.g. coronary heart disease or stroke) 
• Genetic abnormalities, e.g. familial hypercholesterolemia 
Risk Factors 
(Lesser or Uncertain) 
en.wikipedia.org/wiki/Atherosclerosis 
• Being of South Asian ethnicity   
• Obesity 
• Hypercoagulability 
• Postmenopausal estrogen 
deficiency 
• High intake of saturated fat 
• Trans fat intake  
• High carbohydrate intake 
• Elevated serum levels 
of triglycerides 
• Elevated serum levels 
of homocysteine  
•  Elevated serum levels of uric 
acid  
• Elevated serum 
fibrinogen concentrations 
• Elevated serum lipoprotein 
concentrations 
• Chronic systemic 
inflammation  
• Elevated serum insulin levels  
• Short sleep duration 
• Chlamydia pneumoniae 
infection 
• Air pollution 
Risk Factors 
(Total Cardiovascular Risk) 
escardio.org/static_file/Escardio/Guidelines/publications/DYSLIPguidelines-dyslipidemias-FT.pdf 
All guidelines recommend the assessment of Total Cardiovascular Risk 
because, in most people, ASVD is the product of a number of risk factors. 
Many risk assessment systems are available, including Framingham, SCORE 
(Systemic Coronary Risk Estimation),  etc.   
Very simple principles of risk SCORE ‘ assessment can be defined as follows: 
1. Those with known cardiovascular disease (CVD), type 2 diabetes or type 
1 diabetes with microalbuminuria, very high levels of individual risk 
factors, chronic kidney disease (CKD) are automatically at very high or 
high total cardiovascular risk and need active management of all risk 
factors 
2. For all other people, the use of a risk estimation system such as Systemic 
Coronary Risk Estimation (SCORE) is recommended to estimate total 
cardiovascular risk (CV) risk because many people have several risk 
factors which, in combination, may result in unexpectedly high levels of 
total cardiovascular risk 
Risk Factors 
(Total Cardiovascular Risk) 
escardio.org/static_file/Escardio/Guidelines/publications/DYSLIPguidelines-dyslipidemias-FT.pdf 
• SCORE is intended to 
facilitate risk estimation in 
apparently healthy 
persons with no signs of 
clinical or pre-clinical 
disease 
• Patients who have had a 
clinical event such as an 
acute coronary syndrome 
(ACS) or stroke are at high 
risk of a further event and 
automatically qualify for 
intensive risk factor 
evaluation and 
management 
Etiology     
(Genetic and Acquired Factors) 
• The etiology of 
ASVD is unknown, 
but there are 
multiple factors 
that contribute to 
atherosclerotic 
plaque 
progression 
• These include 
genetic and 
acquired factors 
content.onlinejacc.org/article.aspx?articleid=1124505 
Interactive Role of Infection, 
Inflammation and Traditional Risk Factors 
in Atherosclerosis 
 
Mechanisms   
(Key Moments)     
 en.wikipedia.org/wiki/Atherosclerosis 
• Laying in the base of ASVD atherogenesis is the process of 
atheromatous plaques formation due to disturbed lipid  
metabolism (dyslipidemia) that is characterized by 
subendothelial accumulation of abnormal fatty substances with 
inflammatory response   
• The buildup of an atheromatous plaques is a slow process, 
developed over a period of several years 
•  At first, as the plaques grow, only wall thickening occurs without 
any narrowing 
• Stenosis is a late event, which may never occur and is often the 
result of repeated plaque rupture and healing responses, not 
just the atherosclerotic process by itself 
Mechanisms   
(Passions around Dyslipidemia)     
escardio.org/static_file/Escardio/Guidelines/publications/DYSLIPguidelines-dyslipidemias-FT.pdf 
• Dyslipidemia can be developed in different ways and by itself 
and through interaction with other cardiovascular risk factors 
may affect the development of ASVD 
• Dyslipidemia may be related to other diseases (secondary) or to 
the interaction between genetic predisposition and 
environmental factors and cover a broad spectrum of lipid 
abnormalities, some of which are of great importance in ASVD 
prevention 
•  A particular pattern of dyslipidemia, termed the atherogenic 
lipid triad, is more common than others, and consists of the co-
existence of increased very low density lipoprotein (VLDL) 
remnants manifested as mildly elevated triglycerides (TG), 
increased small dense low-density lipoprotein (LDL) particles, 
and reduced high density lipoprotein (HDL) levels  
Mechanisms   
(Progression of Atherosclerosis)     
 reference.medscape.com/article/1612610-overview#a3 
• Processes involved in 
atherosclerosis include 
coagulation, inflammation, 
lipid metabolism, intimal 
injury, and smooth muscle 
cell proliferation  
• Early lesion development is 
marked by lipid retention 
with activation of endothelial 
adhesion molecules 
• Inflammatory macrophages 
play a significant role 
throughout all phases of 
atherosclerotic progression; 
hyperlipidemia-induced 
macrophage infiltration of 
the arterial intima is one of 
the earliest pathologic 
changes 
Mechanisms   
(Pathways in Evolution and Progression of 
Atherosclerotic Lesions)     
 circ.ahajournals.org/content/92/5/1355/F5.expansion.html 
• Roman numerals indicate 
histologically characteristic 
types of lesions  
• The direction of arrows 
indicates sequence in which 
characteristic morphologies 
may change 
• From type I to type IV, 
changes in lesion 
morphology occur primarily 
because of increasing 
accumulation of lipid 
• The loop between types V 
and VI illustrates how 
lesions increase in thickness 
when thrombotic deposits 
form on their surfaces 
• Thrombotic deposits may 
form repeatedly over varied 
time spans in the same 
location and may be the 
principal mechanism for 
gradual occlusion of 
medium-sized arteries 
Mechanisms   
(Schematic Presentation of Evolution and 
Progression of Atherosclerotic Lesions)     
upload.wikimedia.org/wikipedia/commons/9/9a/Endo_dysfunction_Athero.PNG 
Classification 
(Modified AHA Consensus Classification Based on 
Morphologic Descriptions:Nonatherosclerotic intimal 
lesions) 
 reference.medscape.com/medline/abstract/10807742 
Morphology Description Thrombosis 
Intimal 
thickening 
Normal accumulation of smooth 
muscle cells (SMCs) in the intima in 
the absence of lipid or macrophage 
foam cells 
Absent 
Intimal 
xanthoma 
Superficial accumulation of foam 
cells without a necrotic core or 
fibrous cap; based on animal and 
human data, such lesions usually 
regress 
Absent 
Classification 
(Modified AHA Consensus Classification Based on 
Morphologic Descriptions: Progressive 
atherosclerotic lesions) 
 reference.medscape.com/medline/abstract/10807742 
Morphology Description Thrombosis 
Pathologic intimal 
thickening 
SMC-rich plaque with proteoglycan matrix 
and focal accumulation of extracellular lipid 
Absent 
Fibrous cap 
atheroma 
Early necrosis: focal macrophage infiltration 
into areas of lipid pools with an overlying 
fibrous cap 
Late necrosis: loss of matrix and extensive 
cellular debris with an overlying fibrous cap 
Absent 
Thin cap 
fibroatheroma 
A thin, fibrous cap (< 65 µm) infiltrated by 
macrophages and lymphocytes with rare or 
absence of SMCs and a relatively large 
underlying necrotic core; intraplaque 
hemorrhage/fibrin may be present 
Absent 
Classification 
(Modified AHA Consensus Classification Based on 
Morphologic Descriptions: Lesions with acute 
thrombi) 
 reference.medscape.com/medline/abstract/10807742 
 
 
Description Thrombosis 
Plaque rupture 
Fibroatheroma with fibrous cap 
disruption; the luminal thrombus 
communicates with the underlying 
necrotic core 
Occlusive or 
nonocclusive 
Plaque erosion 
Plaque composition, as above; no 
communication of the thrombus with the 
necrotic core; can occur on a plaque 
substrate of pathologic intimal thickening 
or fibroatheroma 
Usually 
nonocclusive 
Calcified nodule 
Eruptive (shedding) of calcified nodules 
with an underlying fibrocalcific plaque 
with minimal or absence of necrosis 
Usually 
nonocclusive 
Classification 
(Modified AHA Consensus Classification Based on 
Morphologic Descriptions: Lesions with healed 
thrombi) 
 reference.medscape.com/medline/abstract/10807742 
Morphology Description Thrombosis 
Fibrotic 
(without 
calcification) 
 
 
 
Fibrocalcific (+/- 
necrotic core) 
Collagen-rich plaque with 
significant luminal stenosis; lesions 
may contain large areas of 
calcification with few inflammatory 
cells and minimal or absence of 
necrosis; these lesions may 
represent healed erosions or 
ruptures 
Absent 
Classification 
(Frederic Classification of Lipid Disorders) 
gpnotebook.co.uk/simplepage.cfm?ID=x20020617063512021840 
LDL - low-density lipoproteins; C - total cholesterol; TG 
- triglycerides; VLDL - very low-density lipoproteins 
Classification 
(International Classification of Diseases (ICD)) 
google.com.ua/webhp?sourceid=chrome-instant&ion=1&espv=2&ie=UTF-8#q=international%20diseases%20classification%2010 
Chapter V 
(F00-F99) Mental and behavioral disorders 
 F00-F09 Organic, including symptomatic, mental disorders 
Chapter IX 
(I00-I99) Diseases of the circulatory system 
 I20-I25 Ischaemic heart diseases 
 (I60-I69) Cerebrovascular diseases 
 I70-I79 Diseases of arteries, arterioles and capillaries   
 170       Atherosclerosis 
  I70.0  Atherosclerosis of aorta 
  I70.1  Atherosclerosis of renal artery  
  I70.2  Atherosclerosis of arteries of extremities  
  I70.8  Atherosclerosis of other arteries 
  I70.9  Generalized and unspecified atherosclerosis 
 
   
 
Classification 
(Overlap of Atherosclerotic Disease) 
healthline.com/health/atherosclerosis#Types2 thelancet.com/cms/attachment/2001932257/2006685340/gr1.jpg 
• Coronary artery 
disease 
• Carotid artery disease 
• Peripheral artery 
disease 
• Kidney disease 
 Patients with one type of ASVD are 
also at risk of having other types 
Clinical Investigation  
(Passions around Symptoms) 
• ASVD is asymptomatic for decades, even most plaque 
ruptures do not produce symptoms until enough narrowing or 
closure of an artery, due to clots, occurs 
• Symptomatic ASVD is typically associated with men in their 40s 
and women in their 50s to 60s 
• Signs and symptoms only occur after severe narrowing or 
closure impedes blood flow to different organs enough to 
induce symptoms and most of the time, patients realize that 
they have the disease   
• Clinical manifestation and picture of ASVD strictly depends from 
a level and  severity lesions of systemic circulation arteries, 
more often aorta, coronary, carotid, iliac, femoral, renal, etc.  
en.wikipedia.org/wiki/Atherosclerosis 
Clinical Investigation  
(Modalities of Symptoms) 
• ASVD causes symptoms by arterial obstruction, embolization of plaque 
material, and weakening with rupture of the arterial wall 
• Obstruction with or without embolization causes ischemia of the circulation 
supplied by the vessel: 
• Ischemic strokes result from ASVD of the carotid arteries and aortic arch, which 
embolize thrombi and atherosclerotic material, as well as local atherosclerosis of 
the cerebral vessels  
– Obstruction of coronary arteries causes myocardial ischemia that may present as 
acute coronary syndromes (acute ST elevation infarct, non-ST elevation infarct, 
and unstable angina), sudden death, or chronic congestive heart failure 
– Obstruction of iliac vessels results in ischemia of the lower extremities 
(claudication) 
– Atherosclerotic aneurysms  show a predilection for the aorta, especially the 
abdominal aorta, that may rupture and cause death by hemorrhage into the 
retroperitoneal space or pleural cavities, depending on the location 
 reference.medscape.com/article/1612610-overview#a5 
Clinical Investigation  
(Involved Organs’ Symptoms) 
• Heart - chest pain of angina and shortness of breath, sweating, 
nausea, dizziness or light-headedness, breathlessness or 
palpitations 
• Brain - dizziness or confusion; weakness or paralysis on one side 
of the body; sudden, severe numbness in any part of the body; 
visual disturbance, including sudden loss of vision; difficulty 
walking, including staggering or veering; coordination problems 
in the arms and hands; and slurred speech or inability to speak  
• Abdomen - dull or cramping pain in the middle of the abdomen, 
usually beginning 15 to 30 minutes after a meal  
• Legs - cramping pain in the leg muscles, especially during 
exercise; if narrowing is severe, there may be pain at rest, cold 
toes and feet, pale or bluish skin and hair loss on the legs 
drugs.com/health-guide/atherosclerosis.html 
Clinical Investigation  
(Physical Examination) 
• A weak or absent pulse below 
the narrowed area of affected 
artery 
• Decreased blood pressure in an 
affected limb 
• Whooshing sounds (bruits) over 
affected arteries  
• Weak pulses 
• Cool skin that is pale or blue in 
an affected limb 
• Hair loss on an affected limb 
• Male erectile dysfunction 
• Numbness in an affected limb 
• The toenails get thicker 
• Weakness in an affected limb 
• Early gray hair 
• Reduced skin turgor 
• Xanthomas and xanthelasma 
• Senile corneal arc 
• Abundant growth of hair on 
the ears (Gabrielli symptom) 
• Vertical or diagonal crease in 
the earlobe (Frank's sign) 
 
eurheartj.oxfordjournals.org/content/ehj/34/28/2159.full.pdf 
Clinical Investigation  
(Xanthoma) 
annalspc.com/article.asp?issn=0974-2069;year=2014;volume=7;issue=2;spage=118;epage=119;aulast=Moorthy 
A 19-year-old male presented with effort angina of 6-month 
duration, which has worsened since 1 month associated with rest 
angina, and postprandial angina.   Extensive xanthoma tuberosum 
around shoulders, elbows, wrists, and sacrum. 
Clinical Investigation  
(Xanthelasma) 
emedicine.medscape.com/article/1213423-overview 
Xanthelasma of four eyelids in patient with hyperlipidemia. Xanthelasma can be 
soft, semisolid, or calcareous. Frequently, they are symmetrical. The upper lids 
are more frequently involved than the lower lids. Xanthelasma have a tendency 
to progress, coalesce, and become permanent. 
Clinical Investigation  
(Vertical or diagonal crease in the earlobe) 
vivajoyhealth.blogspot.com/ 
Hairs protruding out of the ear-tube and crease on the ear lobe have significant 
correlation with higher incidence of coronary risk 
Clinical Investigation  
(Outcomes) 
• Premature death   
• Thrombosis 
• Vascular aneurisms 
•  Severe vascular narrowing 
• Vascular ruptures and hemorrhages  
• Acute ischemic vascular syndromes 
• Chronic multiple organ dysfunction and failure (cognitive 
impairment and dementia, chronic heart failure, chronic kidney 
disease, limb gangrene)   
• Premature aging 
• Etc.  
jpkc.gdmc.edu.cn/blx/10jxwz/tupu/bltp/8xxg10.htm 
Clinical Investigation  
(Thrombosis) 
This cross section reveals a large myocardial infarction involving the anterior 
left ventricular wall and septum. Here is the coronary thrombosis at higher 
magnification. The thrombus occludes the lumen and produces ischemia 
jpkc.gdmc.edu.cn/blx/10jxwz/tupu/bltp/8xxg10.htm 
Clinical Investigation  
(Vascular aneurisms) 
• Different types of (aortic) aneurysm  
• An aneurysm is a bulging, weakened 
area in the wall of a blood vessel 
resulting in an abnormal widening or 
ballooning greater than 50% of the 
vessel's normal diameter (width) 
• An aneurysm may occur in any blood 
vessel, but is most often seen in an 
artery rather than a vein 
hopkinsmedicine.org/healthlibrary/conditions/cardiovascular_diseases/aneurysm_85,p00193/ 
Clinical Investigation  
(Vascular aneurisms) 
Basilar tip aneurysms are usually diagnosed after a subarachnoid hemorrhage 
or workup for cranial nerve dysfunction. The best methods for diagnosing 
basilar tip aneurysms are with CT angiograms and formal cerebral angiograms. 
Non-contrasted head CT scans can illustrate blood in the subarachnoid space if 
the aneurysm has ruptured. 
virtualmedstudent.com/links/neurological/aneurysm_basilar_artery.html 
Clinical Investigation  
(Severe vascular narrowing) 
Different Types of Coronary Plaques by Coronary Computed Tomography 
Angiography (CCTA). The 3 main types of coronary plaques are shown: calcified 
plaques (A, D), non-calcified plaques (B, E) and partially calcified plaques (C, F), 
illustrated in curved planar reformatted and cross-sectional views. 
ntechopen.com/books/coronary-artery-disease-assessment-surgery-prevention/coronary-ct-angiography-and-the-napkin-ring-sign-indicates-high-risk-atherosclerotic-lesions 
Clinical Investigation  
(Severe vascular narrowing) 
 Imaging findings in a patient with bilateral internal carotid artery (ICA) 
atherosclerotic lesions. CT angiography images (a and b) showing critical 
stenosis at the left ICA origin. Localization of level of stenotic ICA in relation to 
the cervical spine bony anatomical landmarks on imaging to plan optimum 
level of exposure (c). A preoperative MRI T2-axial image (d) showing evidence 
of subcortical and deep white matter ischemic lesions. A postoperative MR 
angiography (e and f) showing complete restoration of normal ICA caliber. 
neurologyindia.com/article.asp?issn=0028-3886;year=2011;volume=59;issue=3;spage=390;epage=396;aulast=Misra;type=3 
Clinical Investigation  
(Severe vascular narrowing) 
• Severe atherosclerosis of 
cerebral arteries 
• Atheromatous plaques may 
cause narrowing or occlusion 
of the vascular lumen by 
themselves or after rupture 
and thrombosis 
•  Cholesterol crystals from 
ruptured plaques may 
embolize 
neuropathology-web.org/chapter2/chapter2bCerebralinfarcts.html 
Clinical Investigation  
(Severe vascular narrowing) 
An ischemic ulcer is characterized by a gangrenous skin change in 
the foot or toes. The foot is usually cold to touch with absent 
pedal pulses. The foot is painful to touch with decreased distal 
capillary refills. 
aneskey.com/extremity-conditions 
Clinical Investigation  
(Vascular ruptures and hemorrhages) 
Classification of aortic dissection localization  
eurheartj.oxfordjournals.org/content/35/41/2873 
Clinical Investigation  
(Vascular ruptures and hemorrhages) 
 Hemorrhagic infarcts are most common in embolism. Use of 
thrombolytics or anticoagulants may convert a bland infarct 
into a hemorrhagic one. 
neuropathology-web.org/chapter2/chapter2bCerebralinfarcts.html 
Clinical Investigation  
(Limb gangrene) 
Dry gangrene of the toes showing the areas of total tissue death, 
appearing as black and lighter shades of discoloration of the skin 
demarcating areas of impending gangrene. (Photo contributor: 
Lawrence B. Stack, MD.) 
aneskey.com/extremity-conditions 
Diagnosis 
  
• Blood tests: cholesterol and C-reactive protein levels, 
lipoproteinogram  
• B-mode, Doppler and intravascular ultrasound: degree of any 
blockages in arteries 
• Ankle-brachial index: recognition of peripheral vascular disease, 
which is usually caused by atherosclerosis 
• Electrocardiogram (ECG): reveal  evidence of a previous heart 
attacks 
• Stress test (including echocardiogram): reveal  evidence of a chronic 
coronary artery disease 
•  Vascular catheterization and angiogram: reveal  evidence of 
narrowed, blocked or aneurismatic arteries 
• Other imaging tests (CT, MRA, etc.): reveal  evidence of narrowed or 
blocked arteries, as well as aneurysms and calcium deposits in the 
artery walls 
 mayoclinic.org/diseases-conditions/arteriosclerosis-atherosclerosis/diagnosis-treatment/diagnosis/dxc-20167050 
Diagnosis 
(B-mode ultrasound) 
B-mode ultrasound imaging of the left carotid artery in a long-
axis during a 10 years period follow-up (1998-2008) in a healthy 
man from 45 to 55 years of age.   
ntechopen.com/books/ultrasound-imaging-medical-applications/atherosclerotic-plaque-regression-and-arterial-reverse-remodelling-in-carotid-and-femoral-arteries-b 
Diagnosis 
(B-mode ultrasound) 
Normal intima-media thickness (IMT) appearance (top left), IMT 
measurement example (top right), fatty streak (bottom left), and 
a homogenous hyperechoic nonstenosing plaque (bottom right). 
radiologykey.com/the-role-of-ultrasound-in-the-management-of-cerebrovascular-disease/ 
Diagnosis 
(Doppler ultrasound) 
 The right internal carotid artery stenosis estimated between  
50 - 69% 
radiopaedia.org/articles/ultrasound-assessment-of-carotid-arterial-atherosclerotic-disease 
Diagnosis 
(Intravascular ultrasound) 
Intravascular ultrasound image of a coronary artery (left), with color-coding 
on the right, delineating the lumen (yellow), external elastic membrane (blue) 
and the atherosclerotic plaque burden (green). The percentage stenosis is 
defined as the area of the lumen (yellow) divided by the area of the external 
elastic membrane (blue) times 100. As the plaque burden increases, the 
lumen size will decrease and the degree of stenosis will increase. 
en.wikipedia.org/wiki/Intravascular_ultrasound 
Diagnosis 
(Combine visualization) 
Example of the terminal vertebral 
stenosis as shown in the upper left 
insert of images (large 
arrow, stenosis on arteriogram). On 
the upper right insert, bilateral 
terminal vertebral artery (VA) 
occlusions with reversal of the 
basilar artery (BA) flow. The lower 
inserts show a high-grade proximal 
VA stenosis with a high-
resistance (arrow) preobstructive 
flow (left image) and a velocity 
jet (double arrows) across the 
lesion (right image). EDV, end-
diastolic velocity; PSV, peak systolic 
velocity. 
radiologykey.com/the-role-of-ultrasound-in-the-management-of-cerebrovascular-disease/ 
Diagnosis 
(Ankle-brachial index) 
  
intranet.tdmu.edu.ua/data/kafedra/internal/surgery2/classes_stud/en/med/lik/ptn/surgery/5/Topic%2008.%20Arteries%20occlusive%20diseases.Mesenteric%20artery%20diseases.htm 
Diagnosis 
(Electrocardiogram)  
An old post-infarction scar of the front wall (deep Q in V1- V4). 
The situation is most probably complicated by a suspected 
ventricular aneurysm. ST sections for QRS in V1 -V4 are elevated, 
best seen in V4 where the elevation reminds the Pardee’s wave 
(underlined in red). 
health-tutor.com/myocardial-scar-ecg.html 
Diagnosis 
(Vascular catheterization and angiogram) 
  
intranet.tdmu.edu.ua/data/kafedra/internal/surgery2/classes_stud/en/med/lik/ptn/surgery/5/Topic%2008.%20Arteries%20occlusive%20diseases.Mesenteric%20artery%20diseases.htm 
A multidetector computed tomographic angiogram with three-dimensional 
reconstruction of the iliofemoral arterial circulation. A 50-year-old man with an occluded 
right superficial femoral artery (single long arrow) with reconstituted superficial femoral 
artery at the level of midthigh. Arterial calcifications (short arrows) in the bilateral distal 
superficial femoral arteries. 
Diagnosis 
(Vascular catheterization and angiogram) 
  
intranet.tdmu.edu.ua/data/kafedra/internal/surgery2/classes_stud/en/med/lik/ptn/surgery/5/Topic%2008.%20Arteries%20occlusive%20diseases.Mesenteric%20artery%20diseases.htm 
Three-dimensional computed tomographic angiogram of an abdominal aortic aneurysm 
that displays various aneurysm components, including thrombus, aortic calcification, 
blood circulation, and aneurysm wall. 
Diagnosis 
(Vascular catheterization and angiogram) 
  
intranet.tdmu.edu.ua/data/kafedra/internal/surgery2/classes_stud/en/med/lik/ptn/surgery/5/Topic%2008.%20Arteries%20occlusive%20diseases.Mesenteric%20artery%20diseases.htm 
 Multidetector computed tomography (CT) angiography. Pertinent collateral pathways 
are developed in the event of chronic severe aortoiliac occlusive disease. The collaterals 
include epigastric arteries (large white arrows), an enlarged inferior mesenteric artery 
(white arrowhead), and enlarged lumbar arteries (black arrows). 
Diagnosis 
(Vascular catheterization and angiogram) 
  
intranet.tdmu.edu.ua/data/kafedra/internal/surgery2/classes_stud/en/med/lik/ptn/surgery/5/Topic%2008.%20Arteries%20occlusive%20diseases.Mesenteric%20artery%20diseases.htm 
Multidetector computed tomography angiography of the aortoiliac artery circulation in a 
63-year-old man with buttock claudication. Three-dimensional image reconstruction 
showing intra-arterial calcification of the aorta (large arrows) and right common iliac 
artery (small arrows).  
Treatment 
(Key Points) 
1. Acute and chronic treatment strategies for acute vascular 
events are proven to reduce disability/death but access to 
care is often lacking 
2. Interventions to consider: the polypill approach for primary 
and secondary prevention is a cost-effective and evidence-
based 
3. Percutaneous interventions with stenting and surgeries (by-
pass and endarterectomy) are effective measures for certain 
scenarios of coronary, cerebral and other artery stenosis and 
occlusions 
4. The most cost-effective management of ASVD is one of an 
integrated treatment based on a Total Vascular Risk approach   
casinapioiv.va/content/dam/accademia/pdf/atherosclerosis.pdf 
Treatment 
(Percutaneous interventions with stenting 
and surgeries) 
(1) Progression of coronary artery disease. (A) Atherosclerosis plaque buildup 
in the artery and blood clot occluding blood fow; (B) stent compressing the 
plaque, with widening of the artery; (C) in-stent restenosis decreasing and 
occluding the blood flow. (2) Myocardial infarction highlighting a localized area 
of ischemia and dead heart muscle. 
  
researchgate.net/figure/235436182_fig2_1-Pathophysiological-presentations-and-progression-of-coronary-artery-disease-A 
Treatment 
(Lifestyle Changes) 
• Salt restriction  
• Moderation of alcohol consumption 
• Other dietary changes (vegetables, low-fat dairy 
products, dietary and soluble fibers, whole grains 
and protein from plant sources, reduced in 
saturated fat and cholesterol) 
• Weight reduction 
• Regular physical exercise 
• Smoking cessation  
 
emedicine.medscape.com/article/198475-overview#a3  
Treatment 
(Education) 
• There should be a change in focus in the education of all 
physicians to more strongly emphasize evidence based 
primary prevention of ASVD 
• Education focused on school children, especially targeted 
to create sustainable healthy behavior and sustainable 
control of risk factors 
• Telemedicine has been proven effective in selected world 
regions 
• Engage the media to promote education for ASVD 
prevention, and the need for rapid access to treatment 
• Produce easily accessible (through medical journals and 
internet) guidelines for management of ASVD   
casinapioiv.va/content/dam/accademia/pdf/atherosclerosis.pdf 
Treatment 
(Pharmacotherapy) 
• Cholesterol medications (statins, fibrates, nicotinic acid (niacin), 
omega-3 supplementation, bile acid sequestrants)   
• Anti-inflammatory medications (selective inhibition of Lp-PLA2 
with darapladib ) 
• Anti-platelet medications (aspirin, clopidogrel, etc.) 
• Beta blocker medications (for coronary artery disease) 
• Angiotensin-converting enzyme (ACE) inhibitors   
• Calcium channel blockers   
• Diuretics (for ASVD arterial hypertension) 
• Other medications (to control specific risk factors for 
atherosclerosis, such as diabetes)  
• Efferent therapy (enterosorption, hemadsorption, LDL 
hemadsorption) 
mayoclinic.org/diseases-conditions/arteriosclerosis-atherosclerosis/diagnosis-treatment/treatment/txc-20167054 
Treatment 
(Statins) 
• Statins or HMG-CoA reductase inhibitors, are a class of lipid-
lowering medications that inhibit the enzyme HMG-CoA 
reductase which plays a central role in the production of 
cholesterol 
• Statins have been found to reduce ASVD disease and mortality 
in those who are at high risk 
• Side effects of statins include muscle pain, increased risk 
of diabetes mellitus, and abnormalities in liver enzyme tests 
• A number of statins are on the market: atorvastatin, 
fluvastatin, lovastatin, pitavastatin, pravastatin, 
rosuvastatin and simvastatin 
en.wikipedia.org/wiki/Statin 
Treatment 
(Statins) 
Major recommendations for statin therapy for ASCVD prevention 
circ.ahajournals.org/content/early/2013/11/11/01.cir.0000437738.63853.7a 
2013 ACC/AHA 
Prognosis  
• ASVD leads to the number one cause of death around the 
World for both men and women 
• However, people with ASVD are living longer with better 
quality of life than ever before 
• For many, this is disease can be prevented 
• Even those people genetically programmed for atherosclerosis 
can delay the beginning and worsening of the disease with a 
healthy lifestyle, the right foods, and medication to lower LDL 
cholesterol 
drugs.com/health-guide/atherosclerosis.html 
Prophylaxis 
• Risk factor assessment and modification should begin early in 
life (childhood) 
• Most risk factors can be modified by lifestyle changes as 
opposed to drug or device treatment 
• Solidarity in primary prevention efforts will benefit both the 
individual and the society as a whole 
• Effective treatment reduces the first clinical manifestations of 
ASVD   
• The role of Governments is crucial   
• Aggregate risk factor reduction can decrease cardiovascular 
events by as much as 70% 
• Adequate Secondary prevention measures can reduce 
vascular event recurrence by 75% 
casinapioiv.va/content/dam/accademia/pdf/atherosclerosis.pdf 
Abbreviations  
• ACE - angiotensin-converting 
enzyme 
• ACS - acute coronary syndrome 
• ASCVD -arteriosclerotic 
cardiovascular disease 
• ASVD – atherosclerotic vascular 
disease 
• CKD - chronic kidney disease  
• CCTA - coronary computed 
tomography angiography  
• CT – computer tomography 
• CV - cardiovascular risk  
• CVD - cardiovascular disease 
 
 
• ICD - International Classification 
of Diseases 
• IGT - impaired glucose tolerance  
• HDL – high-density lipoprotein 
• LDL - low-density lipoprotein  
• MRA –  magnetic resonance 
angiogram 
• PAD –peripheral artery disease 
• SCORE - Systemic Coronary Risk 
Estimation 
• TG -triglycerides 
• VLDL - very low-density 
lipoprotein   
 
Diagnostic and treatment guidelines 
Europe 
• ESC/EAS Guidelines for the management of 
dyslipidemias 
• Joint 2016 European Guidelines on 
Cardiovascular Disease Prevention in Clinical 
Practice 
North America 
• 2013 ACC/AHA Guideline on the Treatment of 
Blood Cholesterol to Reduce Atherosclerotic 
Cardiovascular Risk in Adults  
•  Global Recommendations for the Management 
of Dyslipidemia 
 
 
 
 
